NICE gives nod to rivaroxaban as treatment for pulmonary embolism

04/19/2013 | Fox Business

The U.K.'s National Institute for Health and Care Excellence has endorsed the use of anti-clotting drug rivaroxaban in patients with pulmonary embolism. The decision gives doctors an alternative to combined heparin and warfarin to reduce the risk of a repeat embolism.

View Full Article in:

Fox Business

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Compliance Director
Abbott Laboratories
Santa Clara, CA
Junior to Mid-Level FDA Associate
Morgan Lewis
Washington, DC
Product Development Manager, Disposable Medical Products
ASAHI INTECC, Orange County CA R&D Center
Santa Ana, CA
Neurovascular Intervention Product Sales Rep, North East
ASAHI INTECC
Multiple Locations, SL_Multiple Locations
Senior Manager, Compliance
Stryker
Fremont, CA